Feedback / Questions
FYB203 (aflibercept biosimilar) - Amneal, Formycon, Coherus Biosci, Klinge Pharma
Cimerli (ranibizumab-eqrn) - Amneal, Formycon, Coherus Biosci, Teva
https://www.formycon.com/en/blog/press-release/formycon-reports-preliminary-results-for-the-financial-year-2023-and-exceeds-forecast/
Apr 12, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next